Imagion Biosystems Limited
IBXXF
$0.01
$0.00-10.71%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 47.30K | 367.40K | 697.00K | 1.23M | 1.76M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 47.30K | 367.40K | 697.00K | 1.23M | 1.76M |
| Cost of Revenue | 1.36M | 897.70K | 432.70K | 346.50K | 264.10K |
| Gross Profit | -1.32M | -530.40K | 264.20K | 881.00K | 1.49M |
| SG&A Expenses | 953.70K | 908.10K | 870.70K | 1.30M | 1.73M |
| Depreciation & Amortization | 5.60K | 6.70K | 7.90K | 133.10K | 258.10K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.32M | 1.81M | 1.31M | 1.78M | 2.25M |
| Operating Income | -2.28M | -1.45M | -614.50K | -549.60K | -491.80K |
| Income Before Tax | -2.79M | -2.10M | -1.41M | -1.38M | -1.36M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.79 | -2.10 | -1.41 | -1.38 | -1.36 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.79M | -2.10M | -1.41M | -1.38M | -1.36M |
| EBIT | -2.28M | -1.45M | -614.50K | -549.60K | -491.80K |
| EBITDA | -2.27M | -1.43M | -555.50K | -365.50K | -182.70K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.02 | -0.04 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.02 | -0.04 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 1.11B | 813.53M | 517.18M | 348.49M | 179.79M |
| Average Diluted Shares Outstanding | 1.11B | 813.53M | 517.18M | 348.49M | 179.79M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |